Ticker

No recent analyst price targets found for LSB.

Latest News for LSB

LSB Industries, Inc. Schedules 2026 Second Quarter Results Release for Wednesday, July 29th and Conference Call for Thursday, July 30th

OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”) (NYSE: LXU), today announced that it will release its financial results for the second quarter ended June 30, 2026 on July 29, 2026 after the close of the stock market.LSB's management will host a conference call on Thursday, July 30, 2026 at 10:00 am ET / 9:00 am CT to discuss these results. Participating in the call will be Chairman & Chief Executive…

Business Wire • Jul 15, 2026
LSB Industries: Ongoing Margin Execution Is Not Being Appreciated Enough

LSB Industries, a top-5 U.S. ammonia producer, and a nitrogen-oriented chemical specialist has outperforming other material peers and the Russell 2000 meaningfully this year. Despite facing 900bps of potential margin expansion this year, LXU trades at a forward EV/EBITDA of 5.15x–5.25x, over 20% below its 5-year average, and a 60% discount to the sector. Margin growth is driven by strong pricing growth, higher-value…

Seeking Alpha • May 27, 2026
LSB Industries Reaches Agreement Establishing a Pathway to 100% Ownership of El Dorado CCS Project

OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB” or “the Company”), today announced that it has reached an agreement with Lapis Carbon Solutions (“Lapis”) that establishes a strategic pathway for LSB to take full ownership of Project Blue, the carbon capture and sequestration (“CCS”) project currently underway at its El Dorado, Arkansas facility (“the Project”). “The opportunity to achieve…

Business Wire • May 19, 2026
LSBCF Investors Have Opportunity to Join LakeShore Biopharma Co., Ltd Fraud Investigation with the Schall Law Firm

LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or “the Company”) (OTC: LSBCF) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to…

GlobeNewsWire • May 8, 2026
LSB Industries, Inc. Reports Operating Results for the 2026 First Quarter

OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the first quarter ended March 31, 2026. First Quarter 2026 Results and Recent Highlights Net sales of $169.5 million compared to $143.4 million in the first quarter of 2025 Net income of $19.7 million compared to a net loss of $1.6 million in the first quarter of 2025 Diluted EPS…

Business Wire • Apr 29, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for LSB.

No House trades found for LSB.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top